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Abstract
Background: Identifying a precise demarcation line (DL) is indispensable for pathological complete en bloc endoscopic
submucosal dissection (ESD) for early gastric cancer (EGC). We evaluated the useful condition of chromoendoscopy with
indigo carmine and acetic acid for marking dots around lesions before ESD for EGC.
Methods: We examined 98 consecutive patients with 109 intramucosal EGCs (mean diameter, 17.8 ± 12.4 mm; main
histologic type, 96 intestinal and 13 diffuse) resected by en bloc ESD after chromoendoscopy with indigo carmine and
acetic acid between December 2012 and February 2014. The DL was identified by this technique just before ESD (mean
chromoendoscopy observation time, 71.6 s); subsequently, marking dots were placed around the EGC. EGCs were
classified into two groups: useful for identifying the DL or useless. Clinicopathological characteristics and clinical
outcomes were evaluated in each group.
Results: Forty-two of the 109 cases (38.5 %) were determined useful for chromoendoscopy with indigo carmine
and acetic acid. Multivariate analysis with logistic regression showed that macroscopic type (protruded or flat
elevated-type) and atrophic border (the oral side of tumor) were independently associated with the usefulness
of chromoendoscopy using indigo carmine and acetic acid for identifying the DL of EGCs (P < 0.05). The histologically
positive horizontal margin after ESD was 0 % (0/42) in useful cases, and 7.5 % (5/67) in useless cases.
Conclusions: Before ESD, chromoendoscopy with indigo carmine and acetic acid can be used for creating precise
markings in protruded or flat elevated-type EGC or at the atrophic border on the oral side of EGCs.
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Background
Endoscopic submucosal dissection (ESD) is a widely ac-
cepted treatment for early gastric cancer (EGC), and it
can be performed regardless of tumor size, location, or
fibrosis [1–11].
There has been an increase in the number of ESDs for
EGC and a corresponding increase in the number of en
bloc specimens with a positive horizontal margin (HM).
In order to reduce the incidence of positive HMs, it will
be important to improve the diagnostic performance of
magnifying endoscopy with narrow band imaging (ME-
NBI) for identifying a demarcation line (DL), as well as
for improving ESD procedure itself and specimen hand-
ling [12]. Identification of a precise DL is indispensable
for performing pathological complete en bloc ESD for
EGC. In Japan, ME-NBI is a standardized technique for
determining DL of EGCs during ESD [13]. However,
ME-NBI needs to be close to the lesion and takes a long
time to perform when the lesion is of a large size or if
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the lesion is in a position that is difficult to access with
the vertical approach of the scope.
Chromoendoscopy, which has been used in combin-
ation with indigo carmine and acetic acid, has been re-
ported as a novel technique for identifying a DL. This
technique improves the diagnostic yield for delineating
the margin of EGGs [14–16] or diagnosis of gastric neo-
plasia [17], and enables observation without magnification.
However, the useful condition of chromoendoscopy with
indigo carmine and acetic acid for marking dots around
lesions before ESD for all types of ECGs remains unclear.
Therefore, the aim of the present study was to deter-
mine patient- and tumor-related factors for identifying
the DL by chromoendoscopy with indigo carmine and
acetic acid for EGCs.
Methods
Patients
The study group comprised 98 consecutive patients with
109 intramucosal EGCs resected by en bloc ESD after
chromoendoscopy with indigo carmine and acetic acid at
Hiroshima University Hospital between December 2012
and February 2014. We classified the lesions as either use-
ful or useless, according to the visibility of the DL using
chromoendoscopy with indigo carmine and acetic acid.
The indications for ESD were based on the expectation
that the procedure would be curative, as indicated in the
Japanese Classification of Gastric Carcinoma issued by the
JGCA [18]. All patients provided written informed con-
sent for the ESD procedure and follow-up assessment.
The study was conducted in accordance with the Declar-
ation of Helsinki and was approved by the Institutional
Review Board of the Hiroshima University Hospital.
Evaluation of chromoendoscopy with indigo carmine and
acetic acid images
Four expert endoscopists, who experienced in more than
200 gastric ESD cases, participated in our study evalu-
ation. The conventional endoscopic images were pre-
sented to each of the physicians in random order and
blinded for comparison with the chromoendoscopy with
indigo carmine and acetic acid images. Physicians scored
the chromoendoscopy with indigo carmine and acetic acid
images for visibility of the DL according to the following
scale: +2 (improved visibility), +1 (some- what improved
visibility), 0 (visibility equivalent to that of conventional
visibility), −1 (somewhat decreased visibility), and −2 (de-
creased visibility). The 4 physicians’ scores for each chro-
moendoscopy with indigo carmine and acetic acid image
were tallied. If an image had a total score of 7 or 8, the
image was considered useful for determining the while a
score between 6 or less indicated that it was not useful
(Fig. 1).
Fig. 1 Example of useful case and useless case. a Reddish flat lesion with small ulcer is shown at the lesser curvature of the body by conventional
endoscopy; b After dying indigo carmine and acetic acid, the DL became more clearly (this image scored 8, and classified to useful case);
c A normochromic protruded lesion is shown at the posterior wall of the antrum by conventional endoscopy, and the DL can be recognized
as the rising portion of the protruded lesion; d After dying indigo carmine and acetic acid, the DL seems to be not obviously improved (this
image scored 4, and classified to useless case)
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ESD procedure
ESD was performed as previously reported [5, 6, 8, 9, 19].
We identified the DL by white light endoscopy and chro-
moendoscopy with indigo carmine and acetic acid just be-
fore ESD (mean chromoendoscopy observation time,
71.6 s). For chromoendoscopy with indigo carmine and
acetic acid, we initially dyed the tumor with 1.5 % acetic
acid, followed by indigo carmine 30 s later. If the chro-
moendoscopy with indigo carmine and acetic acid were
not useful to determine the DL, we used ME-NBI. After
identifying the DL, marking dots were placed around the
lesion using an argon plasma coagulation probe. An extra
marking dot was placed on the DL of the tumor and con-
firmed by the pathological analysis.
In all patients, the presence or absence of endo-
scopic submucosal fibrosis findings were classified ac-
cording to a previously reported classification [8, 20].
Based on observations at the time of injection of so-
dium hyaluronate with indigo carmine, lesions were
classified as F0 (no fibrosis; manifests as a blue trans-
parent layer), F1 (mild fibrosis; appears as a white
web-like structure in the blue submucosal layers), and
F2 (severe fibrosis, appears as a white muscular struc-
ture without a blue transparent layer in the submucosal
layers). Poor control of bleeding during ESD indicated
the frequent need for coagulation with hemostatic
forceps [19].
Follow-up endoscopy after ESD was performed immedi-
ately after positive HM was identified by pathologic
diagnosis. If there was no local recurrence, surveillance
endoscopy was performed at 3–6, 12, and every 12 months
thereafter, respectively. If the HM was negative, follow-up
endoscopy was performed every 12 months. Biopsy of
the ESD scar site analysis was always performed,
whether or not local recurrent tumor was observed
endoscopically.
Pathologic evaluation of resected specimens
Resected specimens were fixed in formalin solution and
cut into 2-mm thick sections. Histopathological diagnosis
was based on the Japanese Classification of Gastric Car-
cinoma [21]. According to the Japanese Gastric Cancer
Association (JGCA) [18], the absolute indication for cura-
tive ESD are well- or moderately differentiated intramuco-
sal adenocarcinoma tumors that are ≤ 2 cm in diameter
without ulceration, and lymph node metastasis and
lymphatic vessel invasion. The expanded indication
added well- or moderately differentiated intramucosal
adenocarcinoma tumors that are > 2 cm in diameter
without ulceration, well- or moderately differentiated
adenocarcinoma lesions that are ≤ 3 cm in diameter
with submucosal invasion of < 500 μm without ulcer-
ation, and well- or moderately differentiated adenocarcin-
oma with ulceration.
Immunohistochemistry for mucin phenotype of EGC
The immunohistochemical analysis was performed ac-
cording to the method described by Sasaki et al. [22], with
minor modifications. Immunohistochemistry for anti-
human gastric mucin (HGM), MUC2, MUC6, and CD10
was performed on formalin-fixed, paraffin-embedded tis-
sues cut into serial 4 μm sections, respectively. Sections
were deparaffinized and rehydrated in phosphatase-
buffered saline (PBS, PH 7.2) and microwaved twice for
5 min each in Dako REALTarget Retrieval Solution (Dako)
for antigen retrieval. The slides were placed in a humidi-
fied chamber and incubated with protein blocking solution
(5 % normal horse serum and 1 % normal goat serum in
PBS) for 20 min at room temperature. Primary antibodies
were applied to the slides and incubated overnight in
humidified boxes at 4 °C. The primary antibodies that
were used included the HGM monoclonal antibody
(Novocastra, Newcastle, UK) and anti-Muc6 (Novocastra)
for gastric mucin as well as the anti-Muc2 (Novocastra)
and CD10 antibody (Novocastra) for intestinal mucin.
After incubation for 1 h at room temperature with corre-
sponding peroxidase-conjugated secondary antibodies, a
positive reaction was detected by exposure to stable 3,3′-
diaminobenzidine for 5 to 10 min. Slides were counter-
stained with hematoxylin for visualization of the nucleus.
The results of immunostaining were considered positive if
more than 10 % of tumor cells were stained for each
marker. According to the results, tumors were classified
into the gastric (G-type), intestinal (I-type), and mixed
phenotypes (M-type).
Outcome measurements
Clinicopathological characteristics (sex, age, tumor location
[U or M/L], tumor diameter, macroscopic type of tumor
[elevated, 0-I & 0-IIa & 0-IIb; depressed, 0-IIa + IIc & 0-
IIc], color of tumor [reddish/normal or pale], presence of
atrophic border [oral side /anal side of tumor], presence of
intestinal metaplasia around tumor [present/absent], histo-
logic type of tumor [intestinal/diffuse], mucin phenotype of
tumor [G type/I type /M type], depth of tumor [intramuco-
sal/submucosal], presence of ulceration [positive or nega-
tive], visibility of the DL with indigo carmine only) and
clinical outcomes (complete en-bloc resection, degree of
fibrosis during ESD, histologically positive HM, local recur-
rence rate, procedure time, poor control of bleeding during
ESD, perforation, post-ESD bleeding) were compared be-
tween the two groups.
Statistical analysis
Differences between the two groups were analyzed
using the χ2-test with Yates’ correction, Fisher’s exact
test, or Student’s t-test, respectively. A P value of < 0.05
was considered significant.
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Results
Among the cases of chromoendoscopy with indigo car-
mine and acetic acid for marking dots around lesions be-
fore ESD for EGCs, 38.5 % (42/109) were classified as
useful (Fig. 2). The clinicopathological characteristics of
the EGCs are shown in Table 1. Protruded or flat ele-
vated type tumors (including 4 0–IIb lesions), or an
atrophic border, which were located in the oral side of
tumor, and the intestinal type of histology, were signifi-
cantly more frequently identified in cases wherein chro-
moendoscopy images with indigo carmine and acetic
acid were useful for identifying the DL. No type 0–IIb
lesions were observed among the useless cases. There
were no significant differences in the mucin phenotype
of the differentiated type gastric cancers. Clinical out-
comes of ESD for EGCs are demonstrated in Table 2.
The histologically positive horizontal margin after ESD
was 0 % (0/42) in useful cases, and 7.5 % (5/67) in use-
less cases, respectively, but was not statistically signifi-
cant. The tumor margin of these 5 positive HM cases
could not be evaluated because of burn damage caused
by ESD. Furthermore, local recurrence did not occur.
Multivariate analysis with logistic regression revealed
that both “protruded or flat elevated type” and “atrophic
border which exists in the oral side of EGC” were signifi-
cant tumor-related factors for identifying the DL by
chromoendoscopy using indigo carmine and acetic acid
(Table 3).
Discussion
In the present study, in 38.5 % cases, chromoendoscopy
images with indigo carmine and acetic acid could be
used for marking dots around lesions before ESD for
EGCs and there were no histologically positive HM
cases after ESD among these cases. Our results indicate
the number of useful cases diagnosed using chromoen-
doscopy with indigo carmine and acetic acid. We
recognized the limitation of this procedure. As we
showed in Fig. 1, the DLs of some cases were clear with
the conventional endoscopic images alone, and chro-
moendoscopy with indigo carmine and acetic acid for
these cases were scored “0 (visibility equivalent to that
of conventional visibility)”. Therefore, we think that the
“useful” cases were only 38.5 % in the present study.
Regarding the useless cases, NBI magnification is ne-
cessary for determining the precise demarcation line of
EGCs and the clinical course. Kawahara et al. also re-
ported the usefulness of commercialized acetic acid–in-
digo carmine mixture (AIM) to delineate the margin of
EGC accurately [14]. However, the effect of our non-
mixture method was not inferior for detecting the DL in
cases in which chromoendoscopy was useful. Although
the use of both the NBI-ME and chromoendoscopy with
indigo carmine and acetic acid are effective for delineat-
ing the detailed margin of EGC, some issues needed to
be addressed. The usefulness of ME-NBI [13, 23, 24], or
ME with acetic acid [25–28], was reported recently for de-
tecting the DL or to observe microsurface/microvascular
patterns of EGC. Recently, ME-NBI has been widely
accepted in Japan, despite the technical issues that have
been identified. First, the scope used in ME-NBI needs to
be close to the lesion, and sometimes bleeding occurs
from the occasional accidental contact, which subse-
quently makes it difficult to do a precise endoscopic ob-
servation. Secondly, the examination time for ME-NBI
becomes longer with the larger lesions. The marking dots
before ESD are required in a short time. Thirdly, the ME-
NBI needs a dedicated model endoscope. Finally, the en-
doscopist needs to be skilled in the ME-NBI technique.
Conversely, chromoendoscopy with indigo carmine and
acetic acid can be performed in relatively short period of
time (mean observation time of 71.6 s in the present
study), and does not require close proximity to the lesion
or special skills. Nevertheless, chromoendoscopy with in-
digo carmine and acetic acid is not expected to replace
the ME-NBI for all EGCs. However, it also has appropriate
indications. A simple procedure that confirms the DL in
the shortest possible time reduces the endoscopists’ stress.
Therefore, we recommend that endoscopists should use
this technique primarily for marking dots on the EGCs
prior to ESD without ME-NBI. Prospective study is neces-
sary to decide the proper strategy of chromoendoscopy
with indigo carmine and acetic acid, and NBI-ME in the
near future.
We previously reported on the risk factors for positive
HM of EGC resected by en bloc ESD, which included
tumor location in the upper third of the stomach and dis-
satisfaction with the absolute indication for curative ESD
[12]. Therefore, local recurrence due to inaccurate the DL
determination should be avoided. Tumor location in the
upper third of the stomach tends to be difficult to approach
Fig. 2 Flowchart showing the 109 ESD cases included in this study.
ESD, endoscopic submucosal dissection; EGC, early gastric cancer
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with an appropriate distance between tumor and scope
without contact bleeding.
The EGC phenotypes were evaluated using CD10 for
the intestinal brush border, MUC2 for intestinal goblet
cells, human gastric mucin for the gastric foveolar cell,
and MUC6 for gastric pyloric gland, respectively. The ex-
pression using the mucin phenotype can be more easily
and objectively classified using the characteristics of EGCs
that are based on intestinal metaplasia. In addition, the
mucin phenotype is considered useful for analyzing the
correlation between background mucosa and the carcino-
genesis of EGCs [29, 30]. There are few reports on the re-
lationship between the mucin phenotype and the DL.
Yoshino et al. [31] reported that gastric and intestinal type
differentiated adenocarcinomas demonstrate unclear and
distinct margins, respectively. There were no reports
about the usefulness of chromoendoscopy with indigo
carmine and acetic acid according to the different
mucin phenotypes. Our results revealed the absence of
a significant relationship between chromoendoscopy
with indigo carmine and acetic acid and mucin pheno-
type. In the future, more useful immunohistochemical
markers may be evaluated in relation to the tumor
carcinogenesis.
In conclusion, to accurately detect the DL, chromoen-
doscopy should be conducted with indigo carmine and
acetic acid, especially for protruded or flat elevated type
tumors or atrophic borders on the oral side of tumors,
instead of the ME-NBI. A prospective randomized con-
trolled trial involving a larger sample size to compare
the ME-NBI and chromoendoscopy with indigo carmine
and acetic acid is necessary.
Conclusions
Before ESD, chromoendoscopy with indigo carmine and
acetic acid can be used for creating precise markings in
protruded or flat elevated-type EGC or at the atrophic
border on the oral side of EGCs.
Table 1 Characteristics of EGCs between useful and useless groups
Clinicopathological features Useful Useless P value
Number of cases 42 67
Sex (Male/Female) 34/8 53/14 N.S.
Age (years) 71.7 ± 7.4 68.6 ± 10.8 N.S.
Tumor location (U/M/L) 9/16/17 12/18/37 N.S.
Tumor diameter (mm, mean ± SD) 17.5 ± 13.8 19.7 ± 10.1 N.S.
Macroscopic type (protruded or flat elevated/depressed) 23/19 18/49 <0.01
Color (reddish/normal & pale) 12/30 31/36 N.S.
Atrophic border (oral side/anal side of tumor) 38/4 46/21 <0.01
Intestinal metaplasia around tumor (present/absent) 10/32 12/55 N.S.
Histologic type (intestinal/diffuse) 41/1 55/12 <0.05
Mucin phenotype (G-type/I-type/M-type) 14/17/11 18/32/17 N.S.
Depth (intramucosal/submucosal) 38/4 53/14 N.S.
Ulceration (+/−) 1/41 8/59 N.S.
Visibility of DL with indigo carmine only (good/bad) 4/38 13/54 N.S.
U upper stomach, M middle stomach, L lower stomach, G-type Gastric type, I-type Intestinal type, M-type Mix type
Table 2 Clinical outcomes of ESD for EGCs between useful and
useless groups
Clinicopathological features Useful Useless P value
Number of cases 42 67
Complete en-bloc resection 42 59 N.S.
Degree of fibrosis during ESD (F0&F1/F2) 2 12 N.S.
Histologically positive HM 0 5 N.S.
Local recurrence rate (%) 0 0 N.S.
Procedure time (min, mean ± SD) 76 ± 53 95 ± 75 N.S.
Poor control of bleeding During ESD 8 17 N.S.
Perforation 0 4 N.S.
Post-ESD bleeding 1 3 N.S.
HM horizontal margin




Atrophic border (Oral side/anal side of tumor) 3.61 (1.18–13.6) <0.05
Macroscopic type (protruded or flat elevated/
depressed)
2.67 (1.13–6.41) <0.05
Histologic type (intestinal/diffuse) 0.20 (0.01–1.16) N.S.
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